Stock Ticker

  • Loading stock data...

Merck & Co., Inc. (NYSE:MRK) and Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Enter into a License Pact For Tildrakizumab

Boston, MA 09/22/2014 (wallstreetpr) – According to reports, Merck & Co., Inc. (NYSE:MRK) and Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) have decided to enter into a worldwide licensing agreement for tildrakizumab, (MK-3222), investigational therapeutic antibody candidate of MRK. Currently, it is going through Phase 3 registration trials for the treatment of a skill element named chronic plaque […]

Sign Up To Get Our Latest Stocks Alerts